Damage-induced cell-cell communication in different cochlear cell types via two distinct ATP-dependent Ca waves.
Intercellular Ca(2+) waves can coordinate the action of large numbers of cells over significant distances. Recent work in many different systems has indicated that the release of ATP is fundamental for the propagation of most Ca(2+) waves. In the organ of hearing, the cochlea, ATP release is involved in critical signalling events during tissue maturation. ATP-dependent signalling is also implicated in the normal hearing process and in sensing cochlear damage. Here, we show that two distinct Ca(2+) waves are triggered during damage to cochlear explants. Both Ca(2+) waves are elicited by extracellular ATP acting on P2 receptors, but they differ in their source of Ca(2+), their velocity, their extent of spread and the cell type through which they propagate. A slower Ca(2+) wave (14 mum/s) communicates between Deiters' cells and is mediated by P2Y receptors and Ca(2+) release from IP(3)-sensitive stores. In contrast, a faster Ca(2+) wave (41 mum/s) propagates through sensory hair cells and is mediated by Ca(2+) influx from the external environment. Using inhibitors and selective agonists of P2 receptors, we suggest that the faster Ca(2+) wave is mediated by P2X(4) receptors. Thus, in complex tissues, the expression of different receptors determines the propagation of distinct intercellular communication signals.


BACKGROUND
The online version of this article (doi:10.1007/s11302-010-9193-8) contains supplementary material, which is available to authorized users.
Lahne
Manuela
M
Gale
Jonathan E
JE
J Biol Chem. 1996 Nov 15;271(46):29080-7
8910562
Development. 2007 Apr;134(7):1407-17
17329369
Mol Pharmacol. 1997 Jan;51(1):109-18
9016352
Physiology (Bethesda). 2007 Apr;22:131-44
17420304
Hear Res. 1999 Feb;128(1-2):190-6
10082298
Cell Calcium. 2007 Jan;41(1):77-86
16828497
Science. 1996 May 3;272(5262):735-8
8614837
J Physiol. 1990 Sep;428:109-31
2172519
Cell Calcium. 1993 Mar;14(3):245-54
8500138
J Neurophysiol. 1990 May;63(5):1068-74
2358862
Science. 1999 Apr 9;284(5412):339-43
10195903
J Assoc Res Otolaryngol. 2002 Sep;3(3):248-68
12382101
Nature. 2007 Nov 1;450(7166):50-5
17972875
N Engl J Med. 1993 Oct 7;329(15):1092-102
8371732
J Neurobiol. 2004 Nov;61(2):250-66
15389694
J Neurosci Res. 2004 Nov 1;78(3):383-92
15389832
J Neurosci. 2008 May 7;28(19):4918-28
18463245
Stroke. 2007 Feb;38(2 Suppl):674-6
17261713
J Neurosci. 2008 Oct 1;28(40):9939-52
18829952
J Comp Neurol. 2005 Apr 4;484(2):133-43
15736235
Mol Pharmacol. 2004 Apr;65(4):979-85
15044628
Brain Res Dev Brain Res. 2001 Feb 28;126(2):173-82
11248351
J Neurosci. 2003 Mar 15;23(6):2348-56
12657694
Br J Pharmacol. 1997 Aug;121(7):1445-53
9257926
Audiol Neurootol. 2003 Jan-Feb;8(1):28-37
12566690
Mol Pharmacol. 2007 Dec;72(6):1447-56
17785580
Ann N Y Acad Sci. 1999 Nov 28;884:389-409
10842609
J Neurosci. 2001 Apr 1;21(7):2215-23
11264297
Mol Pharmacol. 1998 Jun;53(6):969-73
9614197
J Neurosci. 1999 Aug 15;19(16):6918-29
10436049
Cell Calcium. 2009 Aug;46(2):136-46
19631380
Mol Pharmacol. 1999 Oct;56(4):720-7
10496954
J Pharmacol Exp Ther. 2001 Mar;296(3):1043-50
11181939
J Comp Neurol. 2000 Jun 5;421(3):289-301
10813788
Br J Pharmacol. 2000 Jan;129(2):388-94
10694247
Science. 1995 Feb 3;267(5198):707-11
7839151
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18770-5
19047635
Br J Pharmacol. 2003 Dec;140(7):1177-86
14581177
Mol Pharmacol. 2002 Oct;62(4):957-66
12237343
Curr Biol. 2004 Mar 23;14(6):526-9
15043820
Cell Calcium. 2001 Mar;29(3):191-8
11162856
Neuroreport. 2002 Oct 28;13(15):1979-84
12395104
J Neurosci. 1998 Sep 15;18(18):7152-9
9736638
J Neurosci. 1999 Oct 1;19(19):8377-88
10493739